Nanobody
Nanobodies have become outstanding tools for biomedical research, diagnostics and therapy. Recent advances in the identification and functionalization of target-specific nanobodies now make nanobody-based approaches broadly available to many researches in the field. This book provides a compilation...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Book Chapter |
| Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04231naaaa2201333uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_68529 | ||
| 005 | 20210501 | ||
| 020 | |a books978-3-0365-0379-0 | ||
| 020 | |a 9783036503783 | ||
| 020 | |a 9783036503790 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-0379-0 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Rothbauer, Ulrich |4 edt | |
| 700 | 1 | |a Chames, Patrick |4 edt | |
| 700 | 1 | |a Rothbauer, Ulrich |4 oth | |
| 700 | 1 | |a Chames, Patrick |4 oth | |
| 245 | 1 | 0 | |a Nanobody |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (300 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Nanobodies have become outstanding tools for biomedical research, diagnostics and therapy. Recent advances in the identification and functionalization of target-specific nanobodies now make nanobody-based approaches broadly available to many researches in the field. This book provides a compilation of original research articles and comprehensive reviews covering important and up to date aspects of research on nanobodies and their applications for immunoassays, proteomics, protein crystallization and in vitro and in vivo imaging. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a Bacillus anthracis | ||
| 653 | |a immunoassay | ||
| 653 | |a single-domain antibody | ||
| 653 | |a genetic fusion | ||
| 653 | |a Beta galactosidase | ||
| 653 | |a P-type ATPase | ||
| 653 | |a nanobody | ||
| 653 | |a llama | ||
| 653 | |a Zinc-transport | ||
| 653 | |a Zinc-transporting P-ATPase | ||
| 653 | |a ZntA | ||
| 653 | |a TNF | ||
| 653 | |a fluorescent | ||
| 653 | |a nanobodies | ||
| 653 | |a sensor | ||
| 653 | |a anti-cytokine therapy | ||
| 653 | |a autoimmune disease | ||
| 653 | |a Western equine encephalitis virus | ||
| 653 | |a MagPlex | ||
| 653 | |a toxin | ||
| 653 | |a antibody | ||
| 653 | |a camelid | ||
| 653 | |a vaccine | ||
| 653 | |a biodefense | ||
| 653 | |a hydrogen exchange-mass spectrometry | ||
| 653 | |a virus | ||
| 653 | |a formatting | ||
| 653 | |a Fc-domain | ||
| 653 | |a half-life | ||
| 653 | |a ischemia | ||
| 653 | |a stroke | ||
| 653 | |a MCAO | ||
| 653 | |a single domain antibodies | ||
| 653 | |a phage display | ||
| 653 | |a intrabody | ||
| 653 | |a intracellular antibody | ||
| 653 | |a GTPase RHO | ||
| 653 | |a BRET | ||
| 653 | |a RAS | ||
| 653 | |a chromobodies | ||
| 653 | |a live-cell imaging | ||
| 653 | |a compound screening | ||
| 653 | |a cellular models | ||
| 653 | |a single-domain antibody fragments | ||
| 653 | |a molecular imaging | ||
| 653 | |a molecular therapy | ||
| 653 | |a nuclear imaging | ||
| 653 | |a targeted fluorescence imaging | ||
| 653 | |a intraoperative imaging | ||
| 653 | |a Nanobody | ||
| 653 | |a Single Domain Antibody | ||
| 653 | |a Cancer | ||
| 653 | |a Immunotherapy | ||
| 653 | |a Imaging | ||
| 653 | |a influenza | ||
| 653 | |a influenza B virus | ||
| 653 | |a hemagglutinin | ||
| 653 | |a single domain antibody | ||
| 653 | |a NanobodyTM | ||
| 653 | |a yeast display | ||
| 653 | |a epitope mapping | ||
| 653 | |a GFP | ||
| 653 | |a C. elegans | ||
| 653 | |a development | ||
| 653 | |a drosophila | ||
| 653 | |a zebrafish | ||
| 653 | |a targeted photodynamic therapy | ||
| 653 | |a hepatocyte growth factor receptor | ||
| 653 | |a HGFR | ||
| 653 | |a c-Met | ||
| 653 | |a Met | ||
| 653 | |a VHH | ||
| 653 | |a photosensitizer | ||
| 653 | |a single-domain antibodies | ||
| 653 | |a neurodegenerative diseases | ||
| 653 | |a brain imaging | ||
| 653 | |a blood-brain barrier | ||
| 653 | |a delivery | ||
| 653 | |a Aids | ||
| 653 | |a HIV | ||
| 653 | |a Llama Antibodies | ||
| 653 | |a bi-specific VHH | ||
| 653 | |a pepscan | ||
| 653 | |a competition studies | ||
| 653 | |a co-crystallisation | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/3550 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/68529 |7 0 |z DOAB: description of the publication |